Aviva PLC Bei Gene, Ltd. Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $158,160 - $242,688	1,200 Added 4.91%	25,649 $3.46 Million
Q2 2022 Aug 04, 2022	BUY	$121.11 - $216.05 $326,997 - $583,335	2,700 Added 12.41%	24,449 $3.96 Million
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $29,304 - $53,912	200 Added 0.93%	21,749 $4.1 Million
Q4 2021 Feb 10, 2022	BUY	$248.56 - $389.34 $1.27 Million - $1.99 Million	5,100 Added 31.0%	21,549 $5.84 Million
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $653,702 - $1.06 Million	2,619 Added 18.94%	16,449 $5.97 Million
Q2 2021 Aug 10, 2021	SELL	$292.75 - $367.01 $87,825 - $110,103	-300 Reduced 2.12%	13,830 $4.75 Million
Q1 2021 May 13, 2021	SELL	$260.64 - $382.12 $156,384 - $229,272	-600 Reduced 4.07%	14,130 $4.92 Million
Q4 2020 Feb 10, 2021	SELL	$221.31 - $316.61 $828,584 - $1.19 Million	-3,744 Reduced 20.27%	14,730 $3.81 Million
Q3 2020 Nov 12, 2020	BUY	$189.18 - $286.44 $274,121 - $415,051	1,449 Added 8.51%	18,474 $5.29 Million
Q2 2020 Aug 13, 2020	BUY	$123.9 - $195.41 $20,195 - $31,851	163 Added 0.97%	17,025 $3.21 Million
Q1 2020 May 14, 2020	BUY	$121.84 - $173.19 $158,879 - $225,839	1,304 Added 8.38%	16,862 $2.08 Million
Q4 2019 Feb 10, 2020	BUY	$115.78 - $208.34 $35,312 - $63,543	305 Added 2.0%	15,558 $2.58 Million
Q3 2019 Nov 12, 2019	SELL	$120.61 - $148.29 $174,763 - $214,872	-1,449 Reduced 8.68%	15,253 $1.87 Million
Q2 2019 Jul 30, 2019	BUY	$113.99 - $146.86 $202,332 - $260,676	1,775 Added 11.89%	16,702 $2.07 Million
Q1 2019 May 14, 2019	BUY	$122.82 - $151.83 $20,388 - $25,203	166 Added 1.12%	14,927 $1.97 Million
Q4 2018 Feb 12, 2019	BUY	$107.01 - $175.15 $1.58 Million - $2.59 Million	14,761 New	14,761 $2.07 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.91 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.16 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$935 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$899 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$669 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account